Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:JRSH NASDAQ:MAMK NASDAQ:PMNT NASDAQ:SILO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJRSHJerash Holdings (US)$3.43-0.3%$3.27$2.68▼$4.17$43.69M1.0426,261 shs12,424 shsMAMKMaxsMaking$2.71+5.0%$0.00$2.28▼$4.00$42.89MN/A1.46 million shs356,504 shsPMNTPerfect Moment$0.38-6.1%$0.47$0.22▼$2.14$11.66M-3.74795,833 shs594,555 shsSILOSilo Pharma$0.66-4.9%$0.57$0.41▼$3.37$3.11M0.29472,016 shs290,949 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJRSHJerash Holdings (US)+1.18%+3.30%+6.83%+16.22%+15.05%MAMKMaxsMaking-3.73%+257,999,900.00%+257,999,900.00%+257,999,900.00%+257,999,900.00%PMNTPerfect Moment+8.21%+27.54%-9.27%-58.85%-78.42%SILOSilo Pharma+9.86%+15.72%+15.06%-39.10%-69.94%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationJRSHJerash Holdings (US)2.2477 of 5 stars2.55.01.70.00.01.70.6MAMKMaxsMakingN/AN/AN/AN/AN/AN/AN/AN/APMNTPerfect Moment0.3162 of 5 stars0.03.00.00.00.61.70.0SILOSilo Pharma0.6518 of 5 stars0.04.00.00.00.01.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJRSHJerash Holdings (US) 3.00Buy$4.0016.62% UpsideMAMKMaxsMaking 0.00N/AN/AN/APMNTPerfect Moment 0.00N/AN/AN/ASILOSilo Pharma 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest PMNT, JRSH, MAMK, and SILO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2025JRSHJerash Holdings (US)DA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$4.00(Data available from 7/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJRSHJerash Holdings (US)$145.81M0.30$0.20 per share17.43$5.11 per share0.67MAMKMaxsMakingN/AN/AN/AN/AN/AN/APMNTPerfect Moment$21.50M0.54N/AN/A$0.05 per share7.50SILOSilo Pharma$70K42.27N/AN/A$1.12 per share0.59Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJRSHJerash Holdings (US)-$850K-$0.07N/A∞N/A-0.57%-1.33%-1.05%8/12/2025 (Estimated)MAMKMaxsMakingN/AN/A0.00∞N/AN/AN/AN/AN/APMNTPerfect Moment-$8.72M-$0.99N/A∞N/A-67.38%-513.83%-119.38%8/13/2025 (Estimated)SILOSilo Pharma-$4.39M-$1.17N/A∞N/A-6,420.83%-84.88%-61.81%8/12/2025 (Estimated)Latest PMNT, JRSH, MAMK, and SILO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q1 2026JRSHJerash Holdings (US)$0.10N/AN/AN/A$38.85 millionN/A6/23/2025Q4 2025JRSHJerash Holdings (US)$0.04-$0.01-$0.05-$0.01$32.70 million$29.25 million5/9/2025Q1 2025SILOSilo PharmaN/A-$0.23N/A-$0.23N/A$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthJRSHJerash Holdings (US)$0.205.83%N/AN/A N/AMAMKMaxsMakingN/AN/AN/AN/AN/APMNTPerfect MomentN/AN/AN/AN/AN/ASILOSilo PharmaN/AN/AN/AN/AN/ALatest PMNT, JRSH, MAMK, and SILO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2025JRSHJerash Holdings (US)quarterly$0.056.3%5/30/20255/30/20256/6/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJRSHJerash Holdings (US)N/A2.751.35MAMKMaxsMakingN/AN/AN/APMNTPerfect MomentN/A1.010.70SILOSilo PharmaN/A4.734.73Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJRSHJerash Holdings (US)3.39%MAMKMaxsMakingN/APMNTPerfect Moment23.00%SILOSilo Pharma5.58%Insider OwnershipCompanyInsider OwnershipJRSHJerash Holdings (US)41.70%MAMKMaxsMakingN/APMNTPerfect MomentN/ASILOSilo Pharma4.37%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJRSHJerash Holdings (US)6,00012.70 million7.40 millionNot OptionableMAMKMaxsMakingN/A16.62 millionN/AN/APMNTPerfect Moment3131.08 millionN/AN/ASILOSilo Pharma24.48 million4.29 millionNot OptionablePMNT, JRSH, MAMK, and SILO HeadlinesRecent News About These CompaniesSilo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15July 16, 2025 | globenewswire.comSilo Pharma (NASDAQ:SILO) Raised to "Sell" at Wall Street ZenJuly 14, 2025 | americanbankingnews.comSilo Pharma Secures Exclusive License for CNS PeptidesJuly 10, 2025 | tipranks.comSilo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026 - NasdaqJuly 9, 2025 | nasdaq.comSilo Pharma, Inc. Plans IND Application Submission for PTSD Drug SPC-15 with Potential Phase 1 Trial in 2026July 7, 2025 | quiverquant.comQSilo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025July 7, 2025 | globenewswire.comSilo Pharma Faces Nasdaq Non-Compliance NoticeJuly 3, 2025 | msn.comSilo Pharma and Hoth Therapeutics plan joint venture for obesity treatmentJune 26, 2025 | investing.comSilo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market - MorningstarJune 26, 2025 | morningstar.comMSilo Pharma and Hoth Therapeutics to Form Joint Venture for VA-Developed Obesity Treatment - NasdaqJune 26, 2025 | nasdaq.comSilo Pharma Enters LOI for Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global MarketJune 26, 2025 | jcnnewswire.comJSilo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global MarketJune 25, 2025 | globenewswire.comHoth Therapeutics (HOTH) and Silo Pharma (NASDAQ: SILO) today announced the formation of a 50/50 joint venture to develop a first-in-class GDNF-based therapy licensed from the U.S. Department of Veterans Affairs. The therapy targets obesity and fatty liver disease.June 25, 2025 | prnewswire.comSilo Pharma, Inc.: Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial NearsJune 11, 2025 | finanznachrichten.deSilo Pharma, Inc. Receives Notice of Allowance for Patent Strengthening SPC-15 Treatment for PTSDJune 11, 2025 | quiverquant.comQSilo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial NearsJune 11, 2025 | globenewswire.com16 Companies Announced A Bitcoin Treasury Last Week: ReportJune 9, 2025 | coingape.comCSilo Pharma, Inc. Approves $1 Million Bitcoin Purchase as Treasury Reserve AssetJune 7, 2025 | nasdaq.comSilo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve AssetJune 5, 2025 | globenewswire.comSilo Wellness to Relist as Born Defense, a National Security Investment Issuer Focused on Ending Forever Wars and Upholding the Just War DoctrineJune 2, 2025 | newsfilecorp.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimePMNT, JRSH, MAMK, and SILO Company DescriptionsJerash Holdings (US) NASDAQ:JRSH$3.43 -0.01 (-0.29%) Closing price 04:00 PM EasternExtended Trading$3.42 -0.02 (-0.44%) As of 05:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Jerash Holdings (US), Inc., through its subsidiaries, manufactures and exports customized and ready-made sport and outerwear. The company offers t-shirts; jackets and pullover; pants and shorts; crew neck, polo shirts, and tank tops made from knitted fabric, as well as personal protective equipment. It serves various brand-name retailers in the United States, Hong Kong, Jordan, and internationally. The company was incorporated in 2016 and is headquartered in Fairfield, New Jersey.MaxsMaking NASDAQ:MAMK$2.71 +0.13 (+5.04%) As of 04:00 PM EasternMaxsMaking Inc. is a manufacturer of customized consumer goods. It offers a wide range of customizable products such as backpacks, shopping bags, aprons and other promotional items. MaxsMaking Inc. is based in SHANGHAI.Perfect Moment NASDAQ:PMNT$0.38 -0.02 (-6.06%) Closing price 03:58 PM EasternExtended Trading$0.37 -0.01 (-1.87%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Perfect Moment Ltd., together with its subsidiaries, owns and operates a fashion brand that offers ski, surf, and activewear collections under the brand name of Perfect Moment. It offers skiwear, outerwear, swimwear and activewear for women, men, and children. The company sells its collections directly to customers through e-commerce and to wholesale accounts, as well as through other sales partnerships. Perfect Moment Ltd. was founded in 1984 and is based in London, the United Kingdom.Silo Pharma NASDAQ:SILO$0.66 -0.03 (-4.88%) Closing price 03:59 PM EasternExtended Trading$0.66 0.00 (-0.51%) As of 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Krispy Kreme: A Meme Stock Sugar Rush or a Sustainable Treat? From Zero to Hero? Why GoPro's Rally Could Be More Than It Seems A Smokin’ Hot Entry Point for Chipotle Stock Opens in Q3 Alphabet’s Breakout Quarter Signals a New Leadership Phase Tesla Just Hit a Fork in the Road—Could the Bulls Lose Control? GE Vernova's Q2 Electrifies Stock, What's Next For This Top Name? Is Former Dividend Aristocrat AT&T a Buy After Q2 Earnings? What's Behind Opendoor Technologies' Rally? Is Meme Mania Back? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
